Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced that it...
Waypoint Bio, a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, announced $14.5 million in seed funding...
Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer. He will lead global business development,...
NanoImaging Services, the leading provider of cryo-electron microscopy services to the pharmaceutical and biotechnology communities, and Cube Biotech, a pioneer in membrane protein production...
Providence Therapeutic Holdings Inc., a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and the Ontario...
